Question 1

Has Paul Shiu received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $2,508 in general payments to Paul Shiu across 116 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Paul Shiu did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Paul Shiu come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Amgen	23	$462
Johnson & Johnson(2 entities)	14	$346
AbbVie	15	$288
Novartis	17	$233
Aurinia Pharma U.S., Inc.	9	$190
UCB, Inc.	7	$175
AstraZeneca(2 entities)	6	$156
Organon	4	$125
E.r. Squibb & Sons, L.L.C.	4	$86
Pfizer	3	$69
Sobi, Inc	2	$66
Vertex	2	$63
Boehringer Ingelheim	2	$62
Sanofi	2	$57
ANI Pharmaceuticals, Inc.	2	$48
Lilly USA, LLC	2	$46
GSK	1	$20
Pacira Pharmaceuticals Incorporated	1	$17

Drug	Claims	Cost to plans & patients
MethotrexateMethotrexate Sodium	52	$1,197
Mycophenolate Mofetil	21	$1,172
Hydroxychloroquine Sulfate	33	$1,130
Leflunomide	23	$823
Prednisone	42	$351
Gabapentin	12	$227
Allopurinol	33	$180

Paul Shiu

Payments from drug & device makers

Who reported the general payments

How this compares

Most prescribed under Part D

Other rheumatology in San Mateo